Trends in PCSK9 inhibitor utilization in the United States, Europe, and other countries: An analysis of international sales data - 28/04/22
Doi : 10.1016/j.ahj.2022.02.008
Joseph Edgar Blais, PhD a, Yue Wei, MPH a, Martin Knapp, PhD b, Ian C.K. Wong, PhD a, c, d, Li Wei, PhD c, d, Esther W. Chan, PhD a, d, e, f, ⁎ 
a Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China
b Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, London, UK
c Research Department of Practice and Policy, UCL School of Pharmacy, London, UK
d Laboratory of Data Discovery for Health, Hong Kong SAR, China
e The University of Hong Kong Shenzhen Institute of Research and Innovation, Hong Kong SAR, China
f Department of Pharmacy, HKU-Shenzhen Hospital, Shenzhen, Guangdong, China
⁎Reprint requests: Esther W. Chan, Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, General Office, L02-56 2/F, Laboratory Block LKS Faculty of Medicine, 21 Sassoon Road, Pokfulam, Hong Kong SAR, China.Centre for Safe Medication Practice and Research, Department of Pharmacology and PharmacyThe University of Hong KongGeneral Office, L02-56 2/F, Laboratory Block LKS Faculty of Medicine, 21 Sassoon Road, PokfulamHong Kong SARChina
Graphical Abstract |
Mappa
© 2022
Elsevier Inc. Tutti i diritti riservati.
Vol 248
P. 13-20 - Giugno 2022 Ritorno al numero
Articolo precedente
- Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018
- Alexander R. Zheutlin, Catherine G. Derington, Jordan B. King, Ransmond O. Berchie, Jennifer S. Herrick, Dave L. Dixon, Jordana B. Cohen, Daichi Shimbo, Ian M. Kronish, Joseph J. Saseen, Paul Muntner, Andrew E. Moran, Adam P. Bress
- Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs
- Mahmoud Al Rifai, Dhruv Mahtta, David J. Ramsey, Michelle T. Lee, Chayakrit Krittanawong, Sankar D. Navaneethan, L. Parker Gregg, Laura A. Petersen, Salim S. Virani
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?